Use of Serotonin and Catecholamine Reuptake Inhibitors and Onset of Takotsubo Syndrome
These findings suggest that the use of catecholamine or serotonin reuptake inhibitors may increase the risk of TS. The use of such medications should be carefully considered in TS survivors.
Authors
- SHIRA I. DUNSIGER (ORCID: https://orcid.org/0000-0001-5636-0601)
- Natalie G. Keirns (ORCID: https://orcid.org/0000-0002-1455-7964)
- Junyang Lou (ORCID: https://orcid.org/0000-0003-2628-1288)
- Christopher Song (ORCID: https://orcid.org/0000-0001-9293-6970)
- Janice Tripolone
- Emily C. Gathright (ORCID: https://orcid.org/0000-0002-6418-6639)
- Sara Ouaddi
- Elena Salmoirago‐Blotcher (ORCID: https://orcid.org/0000-0003-4636-8698)
- J. Dawn Abbott
- Christopher Breault
- Christopher Liu (ORCID: https://orcid.org/0000-0003-4775-462X)
Institutions
- Brigham and Women's Hospital (US)
- Ball State University (US)
- Brown University (US)
- Miriam Hospital (US)
- Core Laboratories (United States) (US)
Publication Details
- Journal
- Biopsychosocial Science and Medicine
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1097/psy.0000000000001432
- Citations
- 2
- Primary Topic
- Takotsubo Cardiomyopathy and Associated Phenomena
- Type
- article
- Field-Weighted Citation Impact
- 2.78